BIO International Convention

Boston, MA 5-8 June 2023

We're attending BIO International Convention 2023 to discuss strategic R&D collaborations with biopharma partners that share our commitment to developing better, more personalized treatments for patients.

With high resolution insights and patient stratification biomarkers in over 45 complex diseases, we've now developed the largest drug discovery pipeline of precision targeted therapies in areas of unmet medical need, ready to discuss with you at BIO.

Our approach:

We generate the deepest disease biology insights and enable detailed mechanistic patient stratification in highly heterogeneous diseases.

Informing drug discovery with novel targets matched to patient biology to optimize selection of the right targets and product profiles
Derisking clinical development with biomarkers of drug response to design targeted clinical trials with a greater probability of success
Accelerating drug approvals and deployment with precision diagnostics and risk scores to prescribe new therapies to the patients who will benefit from them.